Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

Chinese Authorities Investigate Taobao Drug Sales

Xinhuanet, 7/08/11

At a press conference on July 8, a spokesperson for China's State Food and Drug Administration (SFDA) said that local authorities in Hangzhou were investigating C2C & B2C e-commerce site Taobao for selling pharmaceuticals online without the necessary license.

Wang Songlin, director of the SFDA's office of inspections, said that any online pharmaceutical sales must be approved by food and drug inspection and management authorities and authorized pursuant to an official "Online Medical Product Sales and Services Permit," and the front page of any website selling medical products must display the website's permit number in a prominent location. Taobao only holds an "Online Medical Product Information Services Permit," meaning it is not authorized to process sales. At present, Wang said, a total of 69 companies are licensed to sell medicine online; 38 of these are licensed to sell to individuals.

Editor's Note: A recent notice on the SFDA website announced that 245 websites selling illegal or fake medicine had been shut down. An additional 40 illegal medicine sites were named in another posting.

Keywords: Wang Songlin law e-commerce Taobao Internet license B2C C2C State Food and Drug Administration online healthcare


Please note, all fields are required.
None of your personal information will be shared with third parties.



The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports